QA: Nanoviricides INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2022_Nanoviricides_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 20,823,779
1 IntangibleAssetsNetIncludingGoodwill 350,118
2 PropertyPlantAndEquipmentNet 9,084,901
3 remainder_Assets 3,515
4 LiabilitiesCurrent 351,146
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,715,059
9 ResearchAndDevelopmentExpense 5,927,570
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -2,387,526
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 30,262,313
1 Liabilities 351,146
2 Expenses 8,642,629
3 Revenues 0
4 StockholdersEquity 29,911,167
5 NetIncome -11,030,155
6 ComprehensiveNetIncome -11,030,155
7 BaseVar 20,821,807
8 EconomicCapitalRatiobeforeLimitedLiability 3.54
9 EconomicCapitalRatio 4.06

Edgar->Model Mapping

Feature Distribution

Change over Time